Gamma Pharmaceuticals’ Joint Venture Company Holyfield Gamma Choice, LLC, Launches the Holyfield Challenge on College Campuses

LAS VEGAS, NV--(Marketwire - March 24, 2010) -

Gamma Pharmaceuticals, Inc. (PINKSHEETS: GMPM): Gamma Pharmaceuticals Inc. (“Gamma” or “the Company”) initiates roll-out of “the Holyfield Challenge” on college campuses through its Joint Venture Company, Holyfield Gamma Choice, LLC. College students participating in the Holyfield Challenge are encouraged to improve academic performance, as well as quality-of-life and health parameters through a healthy body and improved lifestyle program that awards scholarships, jobs and other incentives to participants and their colleges. Holyfield Gamma Choice, LLC utilizes Evander Holyfield, the four-time World Boxing Heavy Weight Champion’s expertise in nutrition and physical training and Gamma’s formulation and marketing know-how to create and supply nutritional products to Holyfield Challenge participants along with wellness programs targeted at the college market. Livingstone College in Salisbury, North Carolina is the first campus to collaborate for the implementation of the Holyfield Challenge.

Peter Cunningham, a Holyfield Gamma Choice LLC management board member, stated, “Livingstone College has worked with Mr. Holyfield to align Holyfield Choice resources and goals with the objectives of the health and wellness components of their curriculum and campus life.” Mr. Cunningham continued, “Holyfield Gamma Choice, LLC anticipates more than 100 college and university campuses will participate in the first year, making this a major healthy lifestyle contributor in communities across the country.” Gamma Pharmaceuticals, Inc. views the college market as a strategic market in which to establish wellness habits and brand loyalty that will carry on throughout consumers’ lives.

On March 1, 2010, Gamma announced the formation of a Joint Venture Company with Boxing World Heavyweight Champion Evander Holyfield. Mr. Holyfield is the only 4-time Boxing World Heavyweight Champion and in unaided focus groups is identified as one of the world’s most recognized athletes. The joint venture, branded “Holyfield Choice,” is formulating and marketing an innovative line of vitamins and nutritional products utilizing Mr. Holyfield’s expertise in nutrition and physical training and Gamma’s formulation and marketing knowhow. Holyfield Choice is closely integrated with Gamma’s existing corporate infrastructure and distribution channels, and currently has four product lines and seven SKUs, with plans for expansion. Under the terms of the venture, Gamma will consolidate the joint venture’s performance into Gamma’s financials.

About Evander Holyfield

Evander Holyfield is a professional boxer from the United States and is the only 4-time World Heavyweight Champion earning him the nickname “The Real Deal.” He is one of the most recognized athletes in the world. Outside of boxing, he has appeared in numerous television shows and movies including a 5th place finish on ABC’s “Dancing with the Stars” in 2005. He is President of the Holyfield Foundation, created to help disadvantaged young people become healthy, successful and productive adults. The Holyfield Foundation strives to strengthen the lives of youth and their families by establishing and funding programs dedicated to their athletic, academic and spiritual development.

About Gamma Pharmaceuticals, Inc.

Gamma Pharmaceuticals, Inc., (www.gammapharma.com) is a marketing and product formulation company selling its own branded products through wholesalers and direct to retailers, both in the US and internationally. Gamma’s core focus is the marketing and sale of vitamins and nutriceuticals, OTC pharmaceutical products and personal care products in the United States and Greater China. Branded nutritional supplements are sold under the trademarks Brilliant Choice™ children’s nutritional supplements featuring the call to action “Mom you’ve made a brilliant choice for you children’s nutrition;" SAVVY™ adult nutritional supplements featuring the call to action, “Be SAVVY Stay Healthy;" and, Jugular Energy Products™ and high performance supplements featuring the call to action, “Go for the Jugular™.” Gamma’s customer focus is on selling products in the Lifestyle of Health & Sustainability (“LOHAS”) marketplace and in the Energy Supplement Market. A series of innovative marketing programs supports Gamma’s product sales and retail partners.

At present Gamma manufactures in North America, and distributes in the United States and China. Gamma’s products utilize proprietary “Gel Delivery Technology®,” to create innovative gel product forms; that give consumers a more pleasant experience. Gel Delivery Technology® characteristics include rapid absorption, convenience and taste great. Market categories Gamma targets are growing as rapidly as 60% per year. Gamma has developed formulas and strategies for Metabolic Syndrome and Diabetes Type II, Stress Reduction, Cognition, Well being, Menopause Symptoms and Personal Care Products. Gamma also develops and manufactures house brands for major retailers. At this time, Gamma has a total of 36 SKUs and holds licenses for 9 SKUs in China.

Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this Press Release regarding any impact the quotation of the Company’s stock has on the Pink Sheets or the lack thereof on the OTCBB, and any other effects of the above are forward-looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.


Contact: Gamma Pharmaceuticals Inc
Joe Cunningham, CFO (jcunningham@gammapharma.com)

Direct: (651) 204 2048
Office: (702) 989 5262

MORE ON THIS TOPIC